World Journal of Gastroenterology - Baishideng Publishing Group

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Cited by in CrossRef

For:	Peng WT, Jiang C, Yang FL, Zhou NQ, Chen KY, Liu JQ, Peng SF, Fu L. Tenofovir amibufenamide vs tenofovir alafenamide for treating chronic hepatitis B: A real-world study. World J Gastroenterol 2023; 29(44): 5907-5918 [PMID: 38111506 DOI: 10.3748/wjg.v29.i44.5907]
URL:	https://www.wjgnet.com/1007-9327/full/v29/i44/5907.htm

(159) (136) (0) (0) (0) (6130) (19)

Number	Citing Articles
1	Yongzheng Hu, Yue Zhang, Wei Jiang. Targeting hepatitis B virus-associated nephropathy: efficacy and challenges of current antiviral treatments. Clinical and Experimental Medicine 2025; 25(1) doi: 10.1007/s10238-025-01584-4
2	Ken Lin, Su-Wen Jiang, Ai-Rong Hu. Management of antiviral treatment for chronic hepatitis B patients with high viral load. World Chinese Journal of Digestology 2024; 32(9) doi: 10.11569/wcjd.v32.i9.625 Abstract(592) \| Core Tip(514) \| Full Article(HTML)(3630) \| Times Cited (0) \| Total Visits (4519) \| Open
3	Hai-Nan Ma, Kai-Sen Cao, Yan-Miao Liu, Cheng Chen, Hang Zhang, Fu-Shan Tang. Tenofovir amibufenamide: A potential alternative for chronic hepatitis B treatment. World Journal of Gastroenterology 2025; 31(10): 102580 doi: 10.3748/wjg.v31.i10.102580 Abstract(591) \| Core Tip(635) \| Full Article(HTML)(2189) \| Full Article (PDF)-370K(185) \| Full Article with Cover (PDF)-625K(210) \| Full Article (XML)-56K(132) \| Audio-2970K(30) \| Peer-Review Report-217K(110) \| Answering Reviewers-149K(114) \| Times Cited (1) \| Total Visits (3234) \| Open
4	Hong You, Rakhi Maiwall, Jing Chen, Sang Hoon Ahn, Kadir Dokmeci, Xiaoguang Dou, Manal El-Sayed, Jian-Gao Fan, Rino Gani, Zhiliang Gao, Jacob George, Hasmik Ghazinian, George Goh, Saeed Hamid, Jinlin Hou, Shang-Chin Huang, Dong Ji, Jidong Jia, Tatsuo Kanda, Jia-Horng Kao, Yoon Jun Kim, Cosmas Rinaldi A. Lesmana, Rosmawati Mohamed, Qin Ning, Necati Ormeci, Motoyuki Otsuka, Diana Payawal, Pham Thanh Thuy, Keo Sailey, Manoj Kumar Sharma, Jose D. Sollano, Jian Sun, Tawesak Tanwandee, Alexander Thompson, Fu-Sheng Wang, Guiqiang Wang, Lai Wei, Grace Lai Hung Wong, Vincent Wai Sun Wong, Eng Kiong Yeoh, Terry Cheuk-Fung Yip, Ming-Lung Yu, Wenhong Zhang, Hui Zhuang, Ching-Lung Lai, Masao Omata, Shiv Kumar Sarin, George Lau. APASL clinical practice guidelines on the management of chronic hepatitis B infection: a 2026 update. Hepatology International 2026; doi: 10.1007/s12072-026-11108-1
5	Zhi-Hao Zeng, Jin-Qing Liu, Min Zhang, Cai-Liang Qiu, Zhen-Yu Xu. Tenofovir amibufenamide in chronic hepatitis B: Lipid changes and 144-week safety with tenofovir disoproxil fumarate-to-tenofovir amibufenamide switch. World Journal of Gastroenterology 2025; 31(26): 109285 doi: 10.3748/wjg.v31.i26.109285 Abstract(290) \| Core Tip(285) \| Full Article(HTML)(1662) \| Full Article (PDF)-1884K(149) \| Full Article with Cover (PDF)-2247K(87) \| Full Article (XML)-95K(65) \| Audio-238K(30) \| Peer-Review Report-331K(77) \| Answering Reviewers-565K(71) \| Supplementary Material-101K(66) \| Times Cited (2) \| Total Visits (2344) \| Open
6	Shenglong Lin, Wanlong Huang, Ziyuan Liao, Huaxi Ma, Wenjun Wu, Minghua Lin, Defu Huang, Haibing Gao. Comparison of lipid profile alterations in chronic hepatitis b patients receiving tenofovir alafenamide or tenofovir disoproxil fumarate. Scientific Reports 2024; 14(1) doi: 10.1038/s41598-024-78656-0
7	Xinye Qiu, Yue Yin, Shibin Zhang, Wei Liu. Effectiveness and safety of tenofovir amibufenamide and tenofovir alafenamide in treating elderly patients diagnosed with decompensated hepatitis B cirrhosis: a retrospective cohort study. Frontiers in Pharmacology 2025; 16 doi: 10.3389/fphar.2025.1545108
8	Shi-Peng Ma, Liang Wang, Yu-Liang Zhang, Xin Wan, Qian Liu, Yu-Lun Tang, Lajpat-Rai Malhi, Shan-Fei Ge. Effects of tenofovir amibufenamide and entecavir on estimated glomerular filtration rate in treatment-naïve patients with chronic hepatitis B. World Journal of Hepatology 2026; 18(2): 114346 doi: 10.4254/wjh.v18.i2.114346 Abstract(162) \| Core Tip(94) \| Full Article(HTML)(441) \| Full Article (PDF)-1064K(110) \| Full Article with Cover (PDF)-1361K(193) \| Full Article (XML)-113K(49) \| Audio-579K(13) \| Peer-Review Report-226K(31) \| Answering Reviewers-213K(34) \| Times Cited (0) \| Total Visits (1059) \| Open
9	Li-li Liu, Yi Feng, Chao-yi Ren, Yi Liu, Ming-hui Zhu, Guo-xiang Hao, Tian-tian Gao. A Real-World Pharmacological Assessment of Tenofovir Amibufenamide and Tenofovir Alafenamide in 48-Week Chronic Hepatitis B Treatment: Efficacy, Safety, and Cost-Effectiveness. Current Medical Science 2025; 45(5) doi: 10.1007/s11596-025-00120-5
10	Shuqi Yang, Yijie Lin, Huatang Zhang, Yanlan Liang, Wenjin Yuan, Xing Wang, Wenwu Lin, Wencong Hong, Zhijun Su, Dawu Zeng, Xueping Yu. Efficacy of TDF, TAF, TMF, and TDF-to-TAF switch in chronic hepatitis B: a network meta-analysis. BMC Gastroenterology 2025; 25(1) doi: 10.1186/s12876-025-04289-w
11	Qing Zhang, Jianhua Xu, Dan Liu, Lilin Wang, Shan Ren, Sujun Zheng, Xinyue Chen, Li Qi, Junfeng Lu. Comparative efficacy and safety of tenofovir amibufenamide vs tenofovir alafenamide in the initial 48-week treatment of high viral load chronic hepatitis B: A single-centre retrospective study. Antiviral Therapy 2024; 29(5) doi: 10.1177/13596535241284226
12	Ruirong Tan, Hua Hua, Siyuan Zhou, Zhimin Yang, Changming Yang, Guo Huang, Jin Zeng, Junning Zhao. Current landscape of innovative drug development and regulatory support in China. Signal Transduction and Targeted Therapy 2025; 10(1) doi: 10.1038/s41392-025-02267-y
13	Xinxin Rong, Guangde Yang, Yuanyuan Xu, He Chen, Xia Wang, Juanjuan Fu, Li Li, Xiucheng Pan. Efficacy and Safety of Tenofovir Amibufenamide and Tenofovir Alafenamide for First‐Time HBV‐Related Decompensated Cirrhosis. Journal of Viral Hepatitis 2025; 32(4) doi: 10.1111/jvh.14029
14	Chuang Jiang, Zhi-Hong Zhang, Jia-Xin Li. Current status of drug therapy for chronic hepatitis B. World Journal of Gastroenterology 2025; 31(2): 99443 doi: 10.3748/wjg.v31.i2.99443 Abstract(628) \| Core Tip(682) \| Full Article(HTML)(3574) \| Full Article (PDF)-471K(270) \| Full Article with Cover (PDF)-719K(219) \| Full Article (XML)-268K(139) \| Audio-727K(21) \| Peer-Review Report-175K(135) \| Answering Reviewers-256K(115) \| Times Cited (4) \| Total Visits (4681) \| Open
15	Li-Yang Meng, Chao-Ting Yang, Jian-Feng Bao, Jin-Song Huang. Effectiveness and safety of tenofovir amibufenamide in chronic hepatitis B patients. World Journal of Gastroenterology 2024; 30(26): 3261-3263 doi: 10.3748/wjg.v30.i26.3261 Abstract(749) \| Core Tip(805) \| Full Article(HTML)(1913) \| Full Article (PDF)-330K(211) \| Full Article with Cover (PDF)-558K(166) \| Full Article (XML)-27K(174) \| Audio-434K(23) \| Peer-Review Report-197K(129) \| Answering Reviewers-54K(122) \| Times Cited (3) \| Total Visits (2464) \| Open
16	Yueran Wu, Xia Li, Xiaopeng Yang, Lijun Lin, Biying Zou, Yulin Chen. Effect of tenofovir alafenamide on immune function and long-term prognosis in patients with chronic hepatitis B-related liver cirrhosis using two-dimensional ultrasound evaluation. Journal of Radiation Research and Applied Sciences 2025; 18(4) doi: 10.1016/j.jrras.2025.102041

All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.